⌘K

Login Start Free

Home/Filings/4/0001181431-12-005722

4//SEC Filing

RAAB G KIRK 4

Accession 0001181431-12-005722

CIK 0001178711other

View on SEC.gov Company Profile

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 4:05 PM ET

Size

5.2 KB

Accession

0001181431-12-005722

Insider Transaction Report

Form 4

Period: 2012-02-01

Transcept Pharmaceuticals IncTSPT

Director

Transactions

Award
Stock Option (right to buy)
2012-02-01+45,000→ 45,000 total
Exercise: $8.09Exp: 2022-02-01→ Common Stock (45,000 underlying)

Footnotes (1)

[F1]The option vests in forty-eight equal monthly installments beginning February 24, 2012.

Documents

1 file

4
rrd332262.xmlPrimary
RAAB ANNUAL GRANT

Issuer

Transcept Pharmaceuticals Inc

CIK 0001178711

Entity typeother

Related Parties

1

filerCIK 0001210530

Filing Metadata

Form type: 4
Filed: Feb 2, 7:00 PM ET
Accepted: Feb 3, 4:05 PM ET
Size: 5.2 KB

View on SEC.gov